nodes	percent_of_prediction	percent_of_DWPC	metapath
Zileuton—UGT1A9—Mycophenolate mofetil—systemic lupus erythematosus	0.213	0.3	CbGbCtD
Zileuton—PTGS1—Dapsone—systemic lupus erythematosus	0.102	0.144	CbGbCtD
Zileuton—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0641	0.0901	CbGbCtD
Zileuton—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0577	0.0812	CbGbCtD
Zileuton—CYP2C9—Dapsone—systemic lupus erythematosus	0.0411	0.0579	CbGbCtD
Zileuton—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0274	0.0385	CbGbCtD
Zileuton—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.027	0.038	CbGbCtD
Zileuton—CYP3A4—Dapsone—systemic lupus erythematosus	0.0239	0.0337	CbGbCtD
Zileuton—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0207	0.0292	CbGbCtD
Zileuton—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0207	0.0292	CbGbCtD
Zileuton—CYP2C9—cardial valve—systemic lupus erythematosus	0.0195	0.205	CbGeAlD
Zileuton—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0178	0.025	CbGbCtD
Zileuton—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0178	0.025	CbGbCtD
Zileuton—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0176	0.0247	CbGbCtD
Zileuton—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0166	0.0234	CbGbCtD
Zileuton—CYP3A4—Prednisone—systemic lupus erythematosus	0.0166	0.0233	CbGbCtD
Zileuton—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.0157	0.0221	CbGbCtD
Zileuton—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.0104	0.0146	CbGbCtD
Zileuton—LTB4R—skin of body—systemic lupus erythematosus	0.00545	0.0571	CbGeAlD
Zileuton—CYP1A2—urine—systemic lupus erythematosus	0.00444	0.0465	CbGeAlD
Zileuton—LTB4R—lymphoid tissue—systemic lupus erythematosus	0.00442	0.0463	CbGeAlD
Zileuton—EPHX2—nephron tubule—systemic lupus erythematosus	0.00431	0.0451	CbGeAlD
Zileuton—CYP2C9—urine—systemic lupus erythematosus	0.00421	0.0441	CbGeAlD
Zileuton—LTB4R—bone marrow—systemic lupus erythematosus	0.00402	0.0421	CbGeAlD
Zileuton—EPHX2—cortex of kidney—systemic lupus erythematosus	0.00368	0.0386	CbGeAlD
Zileuton—LTB4R—lung—systemic lupus erythematosus	0.00364	0.0382	CbGeAlD
Zileuton—UGT1A9—kidney—systemic lupus erythematosus	0.00346	0.0362	CbGeAlD
Zileuton—CYP3A4—urine—systemic lupus erythematosus	0.00321	0.0337	CbGeAlD
Zileuton—EPHX2—tendon—systemic lupus erythematosus	0.00305	0.032	CbGeAlD
Zileuton—EPHX2—lung—systemic lupus erythematosus	0.00268	0.0281	CbGeAlD
Zileuton—ALOX5—connective tissue—systemic lupus erythematosus	0.00266	0.0279	CbGeAlD
Zileuton—CYP1A2—blood plasma—systemic lupus erythematosus	0.00232	0.0243	CbGeAlD
Zileuton—PTGS1—endothelium—systemic lupus erythematosus	0.00226	0.0237	CbGeAlD
Zileuton—CYP2C9—blood plasma—systemic lupus erythematosus	0.0022	0.023	CbGeAlD
Zileuton—PTGS1—blood plasma—systemic lupus erythematosus	0.00201	0.021	CbGeAlD
Zileuton—ALOX5—lymphoid tissue—systemic lupus erythematosus	0.00195	0.0204	CbGeAlD
Zileuton—ALOX5—bone marrow—systemic lupus erythematosus	0.00177	0.0186	CbGeAlD
Zileuton—CYP3A4—blood plasma—systemic lupus erythematosus	0.00168	0.0176	CbGeAlD
Zileuton—ALOX5—lung—systemic lupus erythematosus	0.00161	0.0168	CbGeAlD
Zileuton—ALOX5—nervous system—systemic lupus erythematosus	0.00149	0.0156	CbGeAlD
Zileuton—ALOX5—central nervous system—systemic lupus erythematosus	0.00143	0.015	CbGeAlD
Zileuton—PTGS1—connective tissue—systemic lupus erythematosus	0.00107	0.0112	CbGeAlD
Zileuton—PTGS1—skin of body—systemic lupus erythematosus	0.000965	0.0101	CbGeAlD
Zileuton—PTGS1—kidney—systemic lupus erythematosus	0.00091	0.00953	CbGeAlD
Zileuton—Tiaprofenic acid—PTGS2—systemic lupus erythematosus	0.00077	1	CrCbGaD
Zileuton—CYP3A4—kidney—systemic lupus erythematosus	0.00076	0.00796	CbGeAlD
Zileuton—CYP1A2—lung—systemic lupus erythematosus	0.000744	0.00779	CbGeAlD
Zileuton—PTGS1—tendon—systemic lupus erythematosus	0.000735	0.0077	CbGeAlD
Zileuton—PTGS1—lung—systemic lupus erythematosus	0.000645	0.00675	CbGeAlD
Zileuton—PTGS1—nervous system—systemic lupus erythematosus	0.000597	0.00625	CbGeAlD
Zileuton—PTGS1—central nervous system—systemic lupus erythematosus	0.000575	0.00602	CbGeAlD
Zileuton—Lymphadenopathy—Methotrexate—systemic lupus erythematosus	0.000557	0.0037	CcSEcCtD
Zileuton—Conjunctivitis—Triamcinolone—systemic lupus erythematosus	0.000539	0.00358	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Azathioprine—systemic lupus erythematosus	0.000528	0.00351	CcSEcCtD
Zileuton—Flatulence—Cyclosporine—systemic lupus erythematosus	0.00051	0.00339	CcSEcCtD
Zileuton—Tension—Cyclosporine—systemic lupus erythematosus	0.000508	0.00338	CcSEcCtD
Zileuton—Nervousness—Cyclosporine—systemic lupus erythematosus	0.000503	0.00334	CcSEcCtD
Zileuton—Gastrointestinal disorder—Azathioprine—systemic lupus erythematosus	0.0005	0.00333	CcSEcCtD
Zileuton—CYP3A4—nervous system—systemic lupus erythematosus	0.000499	0.00522	CbGeAlD
Zileuton—Musculoskeletal discomfort—Leflunomide—systemic lupus erythematosus	0.000499	0.00332	CcSEcCtD
Zileuton—Flatulence—Mycophenolate mofetil—systemic lupus erythematosus	0.000498	0.00331	CcSEcCtD
Zileuton—Tension—Mycophenolate mofetil—systemic lupus erythematosus	0.000495	0.0033	CcSEcCtD
Zileuton—Insomnia—Leflunomide—systemic lupus erythematosus	0.000495	0.00329	CcSEcCtD
Zileuton—Nervousness—Mycophenolate mofetil—systemic lupus erythematosus	0.00049	0.00326	CcSEcCtD
Zileuton—Conjunctivitis—Betamethasone—systemic lupus erythematosus	0.000489	0.00325	CcSEcCtD
Zileuton—Conjunctivitis—Dexamethasone—systemic lupus erythematosus	0.000489	0.00325	CcSEcCtD
Zileuton—Dyspepsia—Leflunomide—systemic lupus erythematosus	0.000482	0.00321	CcSEcCtD
Zileuton—Ill-defined disorder—Cyclosporine—systemic lupus erythematosus	0.00048	0.00319	CcSEcCtD
Zileuton—CYP3A4—central nervous system—systemic lupus erythematosus	0.00048	0.00503	CbGeAlD
Zileuton—Feeling abnormal—Azathioprine—systemic lupus erythematosus	0.000478	0.00318	CcSEcCtD
Zileuton—Gastrointestinal disorder—Leflunomide—systemic lupus erythematosus	0.000473	0.00314	CcSEcCtD
Zileuton—Ill-defined disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000468	0.00312	CcSEcCtD
Zileuton—Constipation—Leflunomide—systemic lupus erythematosus	0.000468	0.00311	CcSEcCtD
Zileuton—Pain—Leflunomide—systemic lupus erythematosus	0.000468	0.00311	CcSEcCtD
Zileuton—Malaise—Cyclosporine—systemic lupus erythematosus	0.000467	0.00311	CcSEcCtD
Zileuton—Body temperature increased—Azathioprine—systemic lupus erythematosus	0.000458	0.00305	CcSEcCtD
Zileuton—Malaise—Mycophenolate mofetil—systemic lupus erythematosus	0.000455	0.00303	CcSEcCtD
Zileuton—Feeling abnormal—Leflunomide—systemic lupus erythematosus	0.000451	0.003	CcSEcCtD
Zileuton—Chest pain—Cyclosporine—systemic lupus erythematosus	0.000441	0.00293	CcSEcCtD
Zileuton—Arthralgia—Cyclosporine—systemic lupus erythematosus	0.000441	0.00293	CcSEcCtD
Zileuton—Myalgia—Cyclosporine—systemic lupus erythematosus	0.000441	0.00293	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisolone—systemic lupus erythematosus	0.000437	0.00291	CcSEcCtD
Zileuton—Discomfort—Cyclosporine—systemic lupus erythematosus	0.000435	0.0029	CcSEcCtD
Zileuton—Urticaria—Leflunomide—systemic lupus erythematosus	0.000435	0.00289	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000434	0.0102	CbGpPWpGaD
Zileuton—Body temperature increased—Leflunomide—systemic lupus erythematosus	0.000433	0.00288	CcSEcCtD
Zileuton—Arthralgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00043	0.00286	CcSEcCtD
Zileuton—Myalgia—Mycophenolate mofetil—systemic lupus erythematosus	0.00043	0.00286	CcSEcCtD
Zileuton—Chest pain—Mycophenolate mofetil—systemic lupus erythematosus	0.00043	0.00286	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—RASGRP1—systemic lupus erythematosus	0.000429	0.0101	CbGpPWpGaD
Zileuton—Hypersensitivity—Azathioprine—systemic lupus erythematosus	0.000427	0.00284	CcSEcCtD
Zileuton—Ill-defined disorder—Hydrocortisone—systemic lupus erythematosus	0.000427	0.00284	CcSEcCtD
Zileuton—Malaise—Prednisolone—systemic lupus erythematosus	0.000425	0.00283	CcSEcCtD
Zileuton—Discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000425	0.00283	CcSEcCtD
Zileuton—Malaise—Hydrocortisone—systemic lupus erythematosus	0.000415	0.00276	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.000411	0.00967	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TLR4—systemic lupus erythematosus	0.000407	0.00957	CbGpPWpGaD
Zileuton—Hypersensitivity—Leflunomide—systemic lupus erythematosus	0.000403	0.00268	CcSEcCtD
Zileuton—Ill-defined disorder—Triamcinolone—systemic lupus erythematosus	0.000402	0.00267	CcSEcCtD
Zileuton—Ill-defined disorder—Methylprednisolone—systemic lupus erythematosus	0.000401	0.00267	CcSEcCtD
Zileuton—Diarrhoea—Azathioprine—systemic lupus erythematosus	0.000397	0.00264	CcSEcCtD
Zileuton—Discomfort—Prednisolone—systemic lupus erythematosus	0.000396	0.00264	CcSEcCtD
Zileuton—Myalgia—Hydrocortisone—systemic lupus erythematosus	0.000392	0.00261	CcSEcCtD
Zileuton—Malaise—Triamcinolone—systemic lupus erythematosus	0.000391	0.0026	CcSEcCtD
Zileuton—Malaise—Methylprednisolone—systemic lupus erythematosus	0.00039	0.00259	CcSEcCtD
Zileuton—Pruritus—Leflunomide—systemic lupus erythematosus	0.000387	0.00258	CcSEcCtD
Zileuton—Discomfort—Hydrocortisone—systemic lupus erythematosus	0.000387	0.00257	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Cyclosporine—systemic lupus erythematosus	0.000385	0.00256	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—systemic lupus erythematosus	0.000384	0.00904	CbGpPWpGaD
Zileuton—Dizziness—Azathioprine—systemic lupus erythematosus	0.000383	0.00255	CcSEcCtD
Zileuton—UGT1A9—Phase II conjugation—NAT2—systemic lupus erythematosus	0.000382	0.00899	CbGpPWpGaD
Zileuton—Insomnia—Cyclosporine—systemic lupus erythematosus	0.000382	0.00254	CcSEcCtD
Zileuton—Upper respiratory tract infection—Methotrexate—systemic lupus erythematosus	0.000382	0.00254	CcSEcCtD
Zileuton—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—systemic lupus erythematosus	0.000377	0.00888	CbGpPWpGaD
Zileuton—Somnolence—Cyclosporine—systemic lupus erythematosus	0.000376	0.0025	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Mycophenolate mofetil—systemic lupus erythematosus	0.000375	0.0025	CcSEcCtD
Zileuton—Diarrhoea—Leflunomide—systemic lupus erythematosus	0.000375	0.00249	CcSEcCtD
Zileuton—Insomnia—Mycophenolate mofetil—systemic lupus erythematosus	0.000373	0.00248	CcSEcCtD
Zileuton—Dyspepsia—Cyclosporine—systemic lupus erythematosus	0.000372	0.00247	CcSEcCtD
Zileuton—Myalgia—Triamcinolone—systemic lupus erythematosus	0.000369	0.00245	CcSEcCtD
Zileuton—Vomiting—Azathioprine—systemic lupus erythematosus	0.000369	0.00245	CcSEcCtD
Zileuton—Arthralgia—Methylprednisolone—systemic lupus erythematosus	0.000368	0.00245	CcSEcCtD
Zileuton—Myalgia—Methylprednisolone—systemic lupus erythematosus	0.000368	0.00245	CcSEcCtD
Zileuton—Somnolence—Mycophenolate mofetil—systemic lupus erythematosus	0.000366	0.00244	CcSEcCtD
Zileuton—Rash—Azathioprine—systemic lupus erythematosus	0.000365	0.00243	CcSEcCtD
Zileuton—Dermatitis—Azathioprine—systemic lupus erythematosus	0.000365	0.00243	CcSEcCtD
Zileuton—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	0.000365	0.00243	CcSEcCtD
Zileuton—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	0.000365	0.00243	CcSEcCtD
Zileuton—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	0.000365	0.00243	CcSEcCtD
Zileuton—Discomfort—Triamcinolone—systemic lupus erythematosus	0.000364	0.00242	CcSEcCtD
Zileuton—Discomfort—Methylprednisolone—systemic lupus erythematosus	0.000364	0.00242	CcSEcCtD
Zileuton—Headache—Azathioprine—systemic lupus erythematosus	0.000363	0.00242	CcSEcCtD
Zileuton—Dyspepsia—Mycophenolate mofetil—systemic lupus erythematosus	0.000363	0.00241	CcSEcCtD
Zileuton—Dizziness—Leflunomide—systemic lupus erythematosus	0.000362	0.00241	CcSEcCtD
Zileuton—Pain—Cyclosporine—systemic lupus erythematosus	0.000361	0.0024	CcSEcCtD
Zileuton—Constipation—Cyclosporine—systemic lupus erythematosus	0.000361	0.0024	CcSEcCtD
Zileuton—Conjunctivitis—Methotrexate—systemic lupus erythematosus	0.000356	0.00237	CcSEcCtD
Zileuton—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	0.000356	0.00237	CcSEcCtD
Zileuton—Malaise—Dexamethasone—systemic lupus erythematosus	0.000354	0.00236	CcSEcCtD
Zileuton—Malaise—Betamethasone—systemic lupus erythematosus	0.000354	0.00236	CcSEcCtD
Zileuton—Constipation—Mycophenolate mofetil—systemic lupus erythematosus	0.000352	0.00234	CcSEcCtD
Zileuton—Pain—Mycophenolate mofetil—systemic lupus erythematosus	0.000352	0.00234	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—CCL2—systemic lupus erythematosus	0.000349	0.00821	CbGpPWpGaD
Zileuton—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	0.000348	0.00232	CcSEcCtD
Zileuton—Vomiting—Leflunomide—systemic lupus erythematosus	0.000348	0.00232	CcSEcCtD
Zileuton—Insomnia—Prednisolone—systemic lupus erythematosus	0.000348	0.00231	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—P2RY12—systemic lupus erythematosus	0.000345	0.00812	CbGpPWpGaD
Zileuton—Rash—Leflunomide—systemic lupus erythematosus	0.000345	0.0023	CcSEcCtD
Zileuton—CYP3A4—Liver X Receptor Pathway—RXRA—systemic lupus erythematosus	0.000345	0.00812	CbGpPWpGaD
Zileuton—Dermatitis—Leflunomide—systemic lupus erythematosus	0.000345	0.00229	CcSEcCtD
Zileuton—Nausea—Azathioprine—systemic lupus erythematosus	0.000344	0.00229	CcSEcCtD
Zileuton—Headache—Leflunomide—systemic lupus erythematosus	0.000343	0.00228	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	0.000342	0.00228	CcSEcCtD
Zileuton—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	0.00034	0.00226	CcSEcCtD
Zileuton—Insomnia—Hydrocortisone—systemic lupus erythematosus	0.00034	0.00226	CcSEcCtD
Zileuton—Urticaria—Cyclosporine—systemic lupus erythematosus	0.000336	0.00223	CcSEcCtD
Zileuton—Myalgia—Dexamethasone—systemic lupus erythematosus	0.000335	0.00223	CcSEcCtD
Zileuton—Myalgia—Betamethasone—systemic lupus erythematosus	0.000335	0.00223	CcSEcCtD
Zileuton—Body temperature increased—Cyclosporine—systemic lupus erythematosus	0.000334	0.00222	CcSEcCtD
Zileuton—Discomfort—Dexamethasone—systemic lupus erythematosus	0.000331	0.0022	CcSEcCtD
Zileuton—Discomfort—Betamethasone—systemic lupus erythematosus	0.000331	0.0022	CcSEcCtD
Zileuton—Dyspepsia—Hydrocortisone—systemic lupus erythematosus	0.00033	0.0022	CcSEcCtD
Zileuton—Pain—Prednisolone—systemic lupus erythematosus	0.000329	0.00219	CcSEcCtD
Zileuton—Hepatitis—Methotrexate—systemic lupus erythematosus	0.000329	0.00219	CcSEcCtD
Zileuton—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	0.000327	0.00218	CcSEcCtD
Zileuton—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	0.000326	0.00217	CcSEcCtD
Zileuton—Nausea—Leflunomide—systemic lupus erythematosus	0.000325	0.00216	CcSEcCtD
Zileuton—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	0.000324	0.00216	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000322	0.00214	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000321	0.00214	CcSEcCtD
Zileuton—Pain—Hydrocortisone—systemic lupus erythematosus	0.000321	0.00214	CcSEcCtD
Zileuton—Insomnia—Triamcinolone—systemic lupus erythematosus	0.00032	0.00213	CcSEcCtD
Zileuton—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000319	0.00212	CcSEcCtD
Zileuton—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.000318	0.00211	CcSEcCtD
Zileuton—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.000317	0.00211	CcSEcCtD
Zileuton—ALOX5—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000314	0.0074	CbGpPWpGaD
Zileuton—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000311	0.00207	CcSEcCtD
Zileuton—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000311	0.00207	CcSEcCtD
Zileuton—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.00031	0.00207	CcSEcCtD
Zileuton—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000309	0.00206	CcSEcCtD
Zileuton—Malaise—Prednisone—systemic lupus erythematosus	0.000309	0.00205	CcSEcCtD
Zileuton—Urticaria—Prednisolone—systemic lupus erythematosus	0.000305	0.00203	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CXCL12—systemic lupus erythematosus	0.000305	0.00718	CbGpPWpGaD
Zileuton—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000304	0.00202	CcSEcCtD
Zileuton—Pain—Triamcinolone—systemic lupus erythematosus	0.000302	0.00201	CcSEcCtD
Zileuton—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000299	0.00199	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000298	0.00702	CbGpPWpGaD
Zileuton—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000298	0.00198	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—JAK1—systemic lupus erythematosus	0.000298	0.00701	CbGpPWpGaD
Zileuton—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000297	0.00197	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IFNG—systemic lupus erythematosus	0.000297	0.00698	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—PTGS2—systemic lupus erythematosus	0.000296	0.00696	CbGpPWpGaD
Zileuton—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000292	0.00194	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000292	0.00194	CcSEcCtD
Zileuton—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000292	0.00194	CcSEcCtD
Zileuton—Myalgia—Prednisone—systemic lupus erythematosus	0.000291	0.00194	CcSEcCtD
Zileuton—Arthralgia—Prednisone—systemic lupus erythematosus	0.000291	0.00194	CcSEcCtD
Zileuton—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000291	0.00194	CcSEcCtD
Zileuton—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000291	0.00193	CcSEcCtD
Zileuton—Insomnia—Dexamethasone—systemic lupus erythematosus	0.00029	0.00193	CcSEcCtD
Zileuton—Insomnia—Betamethasone—systemic lupus erythematosus	0.00029	0.00193	CcSEcCtD
Zileuton—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000289	0.00192	CcSEcCtD
Zileuton—Discomfort—Prednisone—systemic lupus erythematosus	0.000288	0.00192	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—PTGS2—systemic lupus erythematosus	0.000284	0.00669	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000283	0.00188	CcSEcCtD
Zileuton—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000282	0.00188	CcSEcCtD
Zileuton—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000282	0.00188	CcSEcCtD
Zileuton—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000282	0.00188	CcSEcCtD
Zileuton—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000281	0.00187	CcSEcCtD
Zileuton—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.00028	0.00186	CcSEcCtD
Zileuton—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000279	0.00186	CcSEcCtD
Zileuton—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000279	0.00186	CcSEcCtD
Zileuton—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000277	0.00184	CcSEcCtD
Zileuton—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000277	0.00184	CcSEcCtD
Zileuton—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000277	0.00184	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000275	0.00648	CbGpPWpGaD
Zileuton—Pain—Betamethasone—systemic lupus erythematosus	0.000274	0.00182	CcSEcCtD
Zileuton—Pain—Dexamethasone—systemic lupus erythematosus	0.000274	0.00182	CcSEcCtD
Zileuton—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.000273	0.00181	CcSEcCtD
Zileuton—LTB4R—G alpha (q) signalling events—F2—systemic lupus erythematosus	0.000271	0.00637	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—CDKN1B—systemic lupus erythematosus	0.000269	0.00634	CbGpPWpGaD
Zileuton—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000269	0.00179	CcSEcCtD
Zileuton—Rash—Cyclosporine—systemic lupus erythematosus	0.000266	0.00177	CcSEcCtD
Zileuton—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000266	0.00177	CcSEcCtD
Zileuton—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000266	0.00177	CcSEcCtD
Zileuton—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000265	0.00177	CcSEcCtD
Zileuton—Headache—Cyclosporine—systemic lupus erythematosus	0.000265	0.00176	CcSEcCtD
Zileuton—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000264	0.00176	CcSEcCtD
Zileuton—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000264	0.00176	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—IL2—systemic lupus erythematosus	0.000264	0.0062	CbGpPWpGaD
Zileuton—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000262	0.00174	CcSEcCtD
Zileuton—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.00026	0.00173	CcSEcCtD
Zileuton—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.00026	0.00173	CcSEcCtD
Zileuton—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.00173	CcSEcCtD
Zileuton—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.00026	0.00173	CcSEcCtD
Zileuton—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000258	0.00172	CcSEcCtD
Zileuton—Malaise—Methotrexate—systemic lupus erythematosus	0.000258	0.00172	CcSEcCtD
Zileuton—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000257	0.00171	CcSEcCtD
Zileuton—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000255	0.0017	CcSEcCtD
Zileuton—Urticaria—Betamethasone—systemic lupus erythematosus	0.000255	0.0017	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000254	0.00169	CcSEcCtD
Zileuton—Dizziness—Prednisolone—systemic lupus erythematosus	0.000254	0.00169	CcSEcCtD
Zileuton—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000254	0.00169	CcSEcCtD
Zileuton—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000254	0.00169	CcSEcCtD
Zileuton—Insomnia—Prednisone—systemic lupus erythematosus	0.000253	0.00168	CcSEcCtD
Zileuton—Nausea—Cyclosporine—systemic lupus erythematosus	0.000251	0.00167	CcSEcCtD
Zileuton—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00025	0.00166	CcSEcCtD
Zileuton—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00025	0.00166	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—MMP9—systemic lupus erythematosus	0.000249	0.00587	CbGpPWpGaD
Zileuton—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.000248	0.00165	CcSEcCtD
Zileuton—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000246	0.00164	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	0.000245	0.00578	CbGpPWpGaD
Zileuton—PTGS1—Eicosanoid Synthesis—PTGS2—systemic lupus erythematosus	0.000245	0.00577	CbGpPWpGaD
Zileuton—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000245	0.00163	CcSEcCtD
Zileuton—LTB4R—GPCRs, Class A Rhodopsin-like—CCR5—systemic lupus erythematosus	0.000244	0.00574	CbGpPWpGaD
Zileuton—Myalgia—Methotrexate—systemic lupus erythematosus	0.000244	0.00162	CcSEcCtD
Zileuton—Chest pain—Methotrexate—systemic lupus erythematosus	0.000244	0.00162	CcSEcCtD
Zileuton—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000244	0.00162	CcSEcCtD
Zileuton—Rash—Prednisolone—systemic lupus erythematosus	0.000242	0.00161	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—F2—systemic lupus erythematosus	0.000242	0.0057	CbGpPWpGaD
Zileuton—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000242	0.00161	CcSEcCtD
Zileuton—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000241	0.00161	CcSEcCtD
Zileuton—Headache—Prednisolone—systemic lupus erythematosus	0.000241	0.0016	CcSEcCtD
Zileuton—Discomfort—Methotrexate—systemic lupus erythematosus	0.000241	0.0016	CcSEcCtD
Zileuton—Constipation—Prednisone—systemic lupus erythematosus	0.000239	0.00159	CcSEcCtD
Zileuton—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000239	0.00159	CcSEcCtD
Zileuton—Rash—Hydrocortisone—systemic lupus erythematosus	0.000237	0.00157	CcSEcCtD
Zileuton—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000236	0.00157	CcSEcCtD
Zileuton—Headache—Hydrocortisone—systemic lupus erythematosus	0.000235	0.00156	CcSEcCtD
Zileuton—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000234	0.00156	CcSEcCtD
Zileuton—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000233	0.00155	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CXCL12—systemic lupus erythematosus	0.000232	0.00547	CbGpPWpGaD
Zileuton—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.00023	0.00153	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	0.000229	0.00538	CbGpPWpGaD
Zileuton—Nausea—Prednisolone—systemic lupus erythematosus	0.000228	0.00152	CcSEcCtD
Zileuton—Pruritus—Dexamethasone—systemic lupus erythematosus	0.000227	0.00151	CcSEcCtD
Zileuton—Pruritus—Betamethasone—systemic lupus erythematosus	0.000227	0.00151	CcSEcCtD
Zileuton—Vomiting—Triamcinolone—systemic lupus erythematosus	0.000225	0.0015	CcSEcCtD
Zileuton—Vomiting—Methylprednisolone—systemic lupus erythematosus	0.000224	0.00149	CcSEcCtD
Zileuton—UGT1A9—Biological oxidations—NAT2—systemic lupus erythematosus	0.000224	0.00526	CbGpPWpGaD
Zileuton—Nausea—Hydrocortisone—systemic lupus erythematosus	0.000223	0.00148	CcSEcCtD
Zileuton—Rash—Triamcinolone—systemic lupus erythematosus	0.000223	0.00148	CcSEcCtD
Zileuton—Dermatitis—Triamcinolone—systemic lupus erythematosus	0.000223	0.00148	CcSEcCtD
Zileuton—Rash—Methylprednisolone—systemic lupus erythematosus	0.000222	0.00148	CcSEcCtD
Zileuton—Dermatitis—Methylprednisolone—systemic lupus erythematosus	0.000222	0.00148	CcSEcCtD
Zileuton—Urticaria—Prednisone—systemic lupus erythematosus	0.000222	0.00148	CcSEcCtD
Zileuton—Headache—Triamcinolone—systemic lupus erythematosus	0.000221	0.00147	CcSEcCtD
Zileuton—Headache—Methylprednisolone—systemic lupus erythematosus	0.000221	0.00147	CcSEcCtD
Zileuton—Body temperature increased—Prednisone—systemic lupus erythematosus	0.000221	0.00147	CcSEcCtD
Zileuton—UGT1A9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	0.00022	0.00519	CbGpPWpGaD
Zileuton—Diarrhoea—Betamethasone—systemic lupus erythematosus	0.000219	0.00146	CcSEcCtD
Zileuton—Diarrhoea—Dexamethasone—systemic lupus erythematosus	0.000219	0.00146	CcSEcCtD
Zileuton—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	0.000213	0.00141	CcSEcCtD
Zileuton—Dizziness—Betamethasone—systemic lupus erythematosus	0.000212	0.00141	CcSEcCtD
Zileuton—Dizziness—Dexamethasone—systemic lupus erythematosus	0.000212	0.00141	CcSEcCtD
Zileuton—Insomnia—Methotrexate—systemic lupus erythematosus	0.000211	0.0014	CcSEcCtD
Zileuton—Nausea—Triamcinolone—systemic lupus erythematosus	0.00021	0.0014	CcSEcCtD
Zileuton—Nausea—Methylprednisolone—systemic lupus erythematosus	0.00021	0.00139	CcSEcCtD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCR5—systemic lupus erythematosus	0.000209	0.00492	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	0.000209	0.00491	CbGpPWpGaD
Zileuton—Somnolence—Methotrexate—systemic lupus erythematosus	0.000208	0.00138	CcSEcCtD
Zileuton—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—systemic lupus erythematosus	0.000206	0.00486	CbGpPWpGaD
Zileuton—CYP2C9—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000206	0.00485	CbGpPWpGaD
Zileuton—Hypersensitivity—Prednisone—systemic lupus erythematosus	0.000206	0.00137	CcSEcCtD
Zileuton—LTB4R—Spinal Cord Injury—TGFB1—systemic lupus erythematosus	0.000206	0.00484	CbGpPWpGaD
Zileuton—Dyspepsia—Methotrexate—systemic lupus erythematosus	0.000205	0.00137	CcSEcCtD
Zileuton—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—systemic lupus erythematosus	0.000205	0.00483	CbGpPWpGaD
Zileuton—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—systemic lupus erythematosus	0.000204	0.00481	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—C3—systemic lupus erythematosus	0.000204	0.00481	CbGpPWpGaD
Zileuton—Vomiting—Betamethasone—systemic lupus erythematosus	0.000204	0.00136	CcSEcCtD
Zileuton—Vomiting—Dexamethasone—systemic lupus erythematosus	0.000204	0.00136	CcSEcCtD
Zileuton—Rash—Dexamethasone—systemic lupus erythematosus	0.000202	0.00135	CcSEcCtD
Zileuton—Rash—Betamethasone—systemic lupus erythematosus	0.000202	0.00135	CcSEcCtD
Zileuton—Dermatitis—Betamethasone—systemic lupus erythematosus	0.000202	0.00134	CcSEcCtD
Zileuton—Dermatitis—Dexamethasone—systemic lupus erythematosus	0.000202	0.00134	CcSEcCtD
Zileuton—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	0.000202	0.00134	CcSEcCtD
Zileuton—Headache—Betamethasone—systemic lupus erythematosus	0.000201	0.00134	CcSEcCtD
Zileuton—Headache—Dexamethasone—systemic lupus erythematosus	0.000201	0.00134	CcSEcCtD
Zileuton—ALOX5—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	0.0002	0.00471	CbGpPWpGaD
Zileuton—Pain—Methotrexate—systemic lupus erythematosus	0.0002	0.00133	CcSEcCtD
Zileuton—PTGS1—Overview of nanoparticle effects—TNF—systemic lupus erythematosus	0.0002	0.0047	CbGpPWpGaD
Zileuton—Pruritus—Prednisone—systemic lupus erythematosus	0.000198	0.00131	CcSEcCtD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—systemic lupus erythematosus	0.000196	0.00461	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—P2RY12—systemic lupus erythematosus	0.000195	0.00459	CbGpPWpGaD
Zileuton—Feeling abnormal—Methotrexate—systemic lupus erythematosus	0.000192	0.00128	CcSEcCtD
Zileuton—PTGS1—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000192	0.00453	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—TNF—systemic lupus erythematosus	0.000192	0.00452	CbGpPWpGaD
Zileuton—Diarrhoea—Prednisone—systemic lupus erythematosus	0.000191	0.00127	CcSEcCtD
Zileuton—Nausea—Dexamethasone—systemic lupus erythematosus	0.000191	0.00127	CcSEcCtD
Zileuton—Nausea—Betamethasone—systemic lupus erythematosus	0.000191	0.00127	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	0.000186	0.00439	CbGpPWpGaD
Zileuton—Urticaria—Methotrexate—systemic lupus erythematosus	0.000185	0.00123	CcSEcCtD
Zileuton—Dizziness—Prednisone—systemic lupus erythematosus	0.000185	0.00123	CcSEcCtD
Zileuton—Body temperature increased—Methotrexate—systemic lupus erythematosus	0.000185	0.00123	CcSEcCtD
Zileuton—PTGS1—Biological oxidations—NAT2—systemic lupus erythematosus	0.000182	0.00429	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—F2—systemic lupus erythematosus	0.000179	0.00422	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—RXRA—systemic lupus erythematosus	0.000179	0.00422	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000178	0.00419	CbGpPWpGaD
Zileuton—Vomiting—Prednisone—systemic lupus erythematosus	0.000178	0.00118	CcSEcCtD
Zileuton—LTB4R—Signaling by GPCR—P2RY12—systemic lupus erythematosus	0.000177	0.00417	CbGpPWpGaD
Zileuton—Rash—Prednisone—systemic lupus erythematosus	0.000176	0.00117	CcSEcCtD
Zileuton—Dermatitis—Prednisone—systemic lupus erythematosus	0.000176	0.00117	CcSEcCtD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—RXRA—systemic lupus erythematosus	0.000175	0.00413	CbGpPWpGaD
Zileuton—Headache—Prednisone—systemic lupus erythematosus	0.000175	0.00116	CcSEcCtD
Zileuton—Hypersensitivity—Methotrexate—systemic lupus erythematosus	0.000172	0.00114	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	0.000169	0.00399	CbGpPWpGaD
Zileuton—Nausea—Prednisone—systemic lupus erythematosus	0.000166	0.0011	CcSEcCtD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	0.000166	0.0039	CbGpPWpGaD
Zileuton—Pruritus—Methotrexate—systemic lupus erythematosus	0.000165	0.0011	CcSEcCtD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	0.000163	0.00383	CbGpPWpGaD
Zileuton—PTGS1—Overview of nanoparticle effects—IL6—systemic lupus erythematosus	0.000161	0.00379	CbGpPWpGaD
Zileuton—LTB4R—Class A/1 (Rhodopsin-like receptors)—CCL2—systemic lupus erythematosus	0.00016	0.00376	CbGpPWpGaD
Zileuton—Diarrhoea—Methotrexate—systemic lupus erythematosus	0.00016	0.00106	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—CCR5—systemic lupus erythematosus	0.000159	0.00375	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—systemic lupus erythematosus	0.000159	0.00374	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—C3—systemic lupus erythematosus	0.000156	0.00366	CbGpPWpGaD
Zileuton—LTB4R—Spinal Cord Injury—IL6—systemic lupus erythematosus	0.000155	0.00365	CbGpPWpGaD
Zileuton—Dizziness—Methotrexate—systemic lupus erythematosus	0.000154	0.00103	CcSEcCtD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000152	0.00358	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUNB—systemic lupus erythematosus	0.00015	0.00354	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	0.000149	0.0035	CbGpPWpGaD
Zileuton—Vomiting—Methotrexate—systemic lupus erythematosus	0.000148	0.000987	CcSEcCtD
Zileuton—Rash—Methotrexate—systemic lupus erythematosus	0.000147	0.000979	CcSEcCtD
Zileuton—Dermatitis—Methotrexate—systemic lupus erythematosus	0.000147	0.000978	CcSEcCtD
Zileuton—Headache—Methotrexate—systemic lupus erythematosus	0.000146	0.000973	CcSEcCtD
Zileuton—UGT1A9—NRF2 pathway—RXRA—systemic lupus erythematosus	0.000143	0.00336	CbGpPWpGaD
Zileuton—CYP1A2—Phase II conjugation—NAT2—systemic lupus erythematosus	0.00014	0.00329	CbGpPWpGaD
Zileuton—Nausea—Methotrexate—systemic lupus erythematosus	0.000139	0.000922	CcSEcCtD
Zileuton—LTB4R—GPCR ligand binding—F2—systemic lupus erythematosus	0.000137	0.00321	CbGpPWpGaD
Zileuton—PTGS1—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	0.000136	0.00321	CbGpPWpGaD
Zileuton—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—systemic lupus erythematosus	0.000136	0.0032	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	0.000135	0.00318	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CXCL12—systemic lupus erythematosus	0.000131	0.00309	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—CRP—systemic lupus erythematosus	0.000129	0.00304	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	0.000129	0.00304	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—NAT2—systemic lupus erythematosus	0.000129	0.00304	CbGpPWpGaD
Zileuton—UGT1A9—Biological oxidations—RXRA—systemic lupus erythematosus	0.000125	0.00295	CbGpPWpGaD
Zileuton—CYP2C9—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000125	0.00294	CbGpPWpGaD
Zileuton—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000124	0.00292	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—RASGRP1—systemic lupus erythematosus	0.000122	0.00288	CbGpPWpGaD
Zileuton—LTB4R—GPCR ligand binding—CCL2—systemic lupus erythematosus	0.000122	0.00286	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—RXRA—systemic lupus erythematosus	0.000121	0.00284	CbGpPWpGaD
Zileuton—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	0.000121	0.00284	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—F2—systemic lupus erythematosus	0.000119	0.00281	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CXCL12—systemic lupus erythematosus	0.000119	0.00281	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—systemic lupus erythematosus	0.000117	0.00276	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—PPARG—systemic lupus erythematosus	0.000113	0.00266	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—RASGRP1—systemic lupus erythematosus	0.000111	0.00262	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—systemic lupus erythematosus	0.000111	0.00261	CbGpPWpGaD
Zileuton—ALOX5—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	0.000109	0.00256	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TLR9—systemic lupus erythematosus	0.000108	0.00254	CbGpPWpGaD
Zileuton—CYP1A2—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	0.000107	0.00251	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—CCL2—systemic lupus erythematosus	0.000106	0.0025	CbGpPWpGaD
Zileuton—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	0.000106	0.00249	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—P2RY12—systemic lupus erythematosus	0.000105	0.00246	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	0.000103	0.00242	CbGpPWpGaD
Zileuton—PTGS1—Biological oxidations—RXRA—systemic lupus erythematosus	0.000102	0.0024	CbGpPWpGaD
Zileuton—CYP2C9—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	0.000101	0.00238	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—ALB—systemic lupus erythematosus	9.91e-05	0.00233	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—HIST2H2AC—systemic lupus erythematosus	9.88e-05	0.00233	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CSK—systemic lupus erythematosus	9.63e-05	0.00227	CbGpPWpGaD
Zileuton—LTB4R—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—systemic lupus erythematosus	9.59e-05	0.00226	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—NAT2—systemic lupus erythematosus	9.58e-05	0.00225	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—JAK1—systemic lupus erythematosus	9.49e-05	0.00223	CbGpPWpGaD
Zileuton—CYP2C9—Metapathway biotransformation—NAT2—systemic lupus erythematosus	9.45e-05	0.00222	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	9.23e-05	0.00217	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	9.05e-05	0.00213	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IFNG—systemic lupus erythematosus	9.05e-05	0.00213	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—CCR5—systemic lupus erythematosus	8.99e-05	0.00212	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2RA—systemic lupus erythematosus	8.86e-05	0.00209	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NCF2—systemic lupus erythematosus	8.81e-05	0.00207	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—C3—systemic lupus erythematosus	8.79e-05	0.00207	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—LYN—systemic lupus erythematosus	8.75e-05	0.00206	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—PTGS2—systemic lupus erythematosus	8.67e-05	0.00204	CbGpPWpGaD
Zileuton—CYP1A2—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	8.64e-05	0.00203	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—JAK1—systemic lupus erythematosus	8.62e-05	0.00203	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—SH2B3—systemic lupus erythematosus	8.58e-05	0.00202	CbGpPWpGaD
Zileuton—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—systemic lupus erythematosus	8.22e-05	0.00194	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—NAT2—systemic lupus erythematosus	8.19e-05	0.00193	CbGpPWpGaD
Zileuton—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—systemic lupus erythematosus	8.18e-05	0.00193	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCR5—systemic lupus erythematosus	8.17e-05	0.00192	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.08e-05	0.0019	CbGpPWpGaD
Zileuton—CYP1A2—Metapathway biotransformation—NAT2—systemic lupus erythematosus	8.07e-05	0.0019	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2RA—systemic lupus erythematosus	8.05e-05	0.00189	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—C3—systemic lupus erythematosus	7.98e-05	0.00188	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—F2—systemic lupus erythematosus	7.72e-05	0.00182	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—systemic lupus erythematosus	7.63e-05	0.0018	CbGpPWpGaD
Zileuton—UGT1A9—PPARA activates gene expression—EP300—systemic lupus erythematosus	7.4e-05	0.00174	CbGpPWpGaD
Zileuton—UGT1A9—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—systemic lupus erythematosus	7.24e-05	0.00171	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—RXRA—systemic lupus erythematosus	7.24e-05	0.0017	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NAT2—systemic lupus erythematosus	7.19e-05	0.00169	CbGpPWpGaD
Zileuton—CYP2C9—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	7.17e-05	0.00169	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CXCL12—systemic lupus erythematosus	7.04e-05	0.00166	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—F2—systemic lupus erythematosus	7.01e-05	0.00165	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JUNB—systemic lupus erythematosus	6.91e-05	0.00163	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—systemic lupus erythematosus	6.83e-05	0.00161	CbGpPWpGaD
Zileuton—EPHX2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	6.72e-05	0.00158	CbGpPWpGaD
Zileuton—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—systemic lupus erythematosus	6.67e-05	0.00157	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—RASGRP1—systemic lupus erythematosus	6.57e-05	0.00155	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—systemic lupus erythematosus	6.55e-05	0.00154	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—PRL—systemic lupus erythematosus	6.37e-05	0.0015	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—NAT2—systemic lupus erythematosus	6.32e-05	0.00149	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—CCL2—systemic lupus erythematosus	6.25e-05	0.00147	CbGpPWpGaD
Zileuton—CYP3A4—Metapathway biotransformation—NAT2—systemic lupus erythematosus	6.23e-05	0.00147	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—systemic lupus erythematosus	6.2e-05	0.00146	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—systemic lupus erythematosus	6.2e-05	0.00146	CbGpPWpGaD
Zileuton—CYP1A2—Arachidonic acid metabolism—PTGS2—systemic lupus erythematosus	6.12e-05	0.00144	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—systemic lupus erythematosus	6.07e-05	0.00143	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—TNF—systemic lupus erythematosus	5.85e-05	0.00138	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—systemic lupus erythematosus	5.72e-05	0.00135	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	5.71e-05	0.00134	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—TYK2—systemic lupus erythematosus	5.67e-05	0.00134	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—systemic lupus erythematosus	5.44e-05	0.00128	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—EP300—systemic lupus erythematosus	5.44e-05	0.00128	CbGpPWpGaD
Zileuton—CYP2C9—Biological oxidations—RXRA—systemic lupus erythematosus	5.37e-05	0.00126	CbGpPWpGaD
Zileuton—LTB4R—GPCR downstream signaling—IL2—systemic lupus erythematosus	5.2e-05	0.00122	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—systemic lupus erythematosus	5.16e-05	0.00121	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	5.14e-05	0.00121	CbGpPWpGaD
Zileuton—UGT1A9—NRF2 pathway—TGFB1—systemic lupus erythematosus	5.13e-05	0.00121	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—JAK1—systemic lupus erythematosus	5.09e-05	0.0012	CbGpPWpGaD
Zileuton—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—systemic lupus erythematosus	4.99e-05	0.00117	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCR5—systemic lupus erythematosus	4.83e-05	0.00114	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	4.81e-05	0.00113	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2RA—systemic lupus erythematosus	4.76e-05	0.00112	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—systemic lupus erythematosus	4.73e-05	0.00111	CbGpPWpGaD
Zileuton—PTGS1—Selenium Micronutrient Network—IL6—systemic lupus erythematosus	4.72e-05	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL2—systemic lupus erythematosus	4.72e-05	0.00111	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—C3—systemic lupus erythematosus	4.72e-05	0.00111	CbGpPWpGaD
Zileuton—CYP1A2—Biological oxidations—RXRA—systemic lupus erythematosus	4.59e-05	0.00108	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PPARG—systemic lupus erythematosus	4.57e-05	0.00108	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	4.49e-05	0.00106	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor—TNF—systemic lupus erythematosus	4.42e-05	0.00104	CbGpPWpGaD
Zileuton—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—systemic lupus erythematosus	4.42e-05	0.00104	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—F2—systemic lupus erythematosus	4.14e-05	0.000974	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—ALB—systemic lupus erythematosus	4.11e-05	0.000968	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—RXRA—systemic lupus erythematosus	4.03e-05	0.000948	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CD80—systemic lupus erythematosus	3.97e-05	0.000934	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—NOS3—systemic lupus erythematosus	3.93e-05	0.000926	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	3.92e-05	0.000923	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NAT2—systemic lupus erythematosus	3.82e-05	0.0009	CbGpPWpGaD
Zileuton—ALOX5—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	3.74e-05	0.00088	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CCL2—systemic lupus erythematosus	3.69e-05	0.000869	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—PTGS2—systemic lupus erythematosus	3.6e-05	0.000847	CbGpPWpGaD
Zileuton—CYP3A4—Biological oxidations—RXRA—systemic lupus erythematosus	3.54e-05	0.000834	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TYK2—systemic lupus erythematosus	3.35e-05	0.000789	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—NOS3—systemic lupus erythematosus	3.29e-05	0.000774	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NAT2—systemic lupus erythematosus	3.12e-05	0.000733	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	3.04e-05	0.000715	CbGpPWpGaD
Zileuton—EPHX2—Metabolism—EP300—systemic lupus erythematosus	2.99e-05	0.000704	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.85e-05	0.000671	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL2—systemic lupus erythematosus	2.79e-05	0.000656	CbGpPWpGaD
Zileuton—LTB4R—Signaling by GPCR—IL6—systemic lupus erythematosus	2.77e-05	0.000653	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.73e-05	0.000643	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—MMP9—systemic lupus erythematosus	2.64e-05	0.000621	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.63e-05	0.000619	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PPARG—systemic lupus erythematosus	2.54e-05	0.000599	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—EP300—systemic lupus erythematosus	2.5e-05	0.000589	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	2.48e-05	0.000583	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	2.39e-05	0.000563	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.37e-05	0.000558	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—ALB—systemic lupus erythematosus	2.29e-05	0.000538	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	2.23e-05	0.000524	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—NOS3—systemic lupus erythematosus	2.19e-05	0.000515	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.17e-05	0.000512	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—RXRA—systemic lupus erythematosus	2.14e-05	0.000504	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	2.06e-05	0.000485	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—PTGS2—systemic lupus erythematosus	2e-05	0.000471	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.99e-05	0.000468	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.95e-05	0.000459	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—systemic lupus erythematosus	1.76e-05	0.000415	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—RXRA—systemic lupus erythematosus	1.75e-05	0.000411	CbGpPWpGaD
Zileuton—ALOX5—Metabolism—EP300—systemic lupus erythematosus	1.66e-05	0.000392	CbGpPWpGaD
Zileuton—LTB4R—Signaling Pathways—IL6—systemic lupus erythematosus	1.64e-05	0.000386	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NAT2—systemic lupus erythematosus	1.64e-05	0.000386	CbGpPWpGaD
Zileuton—PTGS1—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	1.62e-05	0.000381	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NAT2—systemic lupus erythematosus	1.4e-05	0.00033	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PPARG—systemic lupus erythematosus	1.35e-05	0.000318	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.3e-05	0.000306	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—ALB—systemic lupus erythematosus	1.22e-05	0.000286	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1.17e-05	0.000276	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—NOS3—systemic lupus erythematosus	1.16e-05	0.000274	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—systemic lupus erythematosus	1.11e-05	0.000262	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PPARG—systemic lupus erythematosus	1.1e-05	0.00026	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	1.08e-05	0.000254	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—PTGS2—systemic lupus erythematosus	1.06e-05	0.000251	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	1.02e-05	0.000241	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—ALB—systemic lupus erythematosus	1e-05	0.000235	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—ALB—systemic lupus erythematosus	9.92e-06	0.000233	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—NOS3—systemic lupus erythematosus	9.49e-06	0.000223	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—RXRA—systemic lupus erythematosus	9.18e-06	0.000216	CbGpPWpGaD
Zileuton—UGT1A9—Metabolism—EP300—systemic lupus erythematosus	8.85e-06	0.000208	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	8.75e-06	0.000206	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—PTGS2—systemic lupus erythematosus	8.68e-06	0.000204	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	8.52e-06	0.000201	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	7.85e-06	0.000185	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	7.28e-06	0.000171	CbGpPWpGaD
Zileuton—PTGS1—Metabolism—EP300—systemic lupus erythematosus	7.22e-06	0.00017	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	6.06e-06	0.000143	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	5.8e-06	0.000136	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	5.21e-06	0.000123	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	4.99e-06	0.000117	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	4.95e-06	0.000117	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	4.56e-06	0.000107	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	4.46e-06	0.000105	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	4.26e-06	0.0001	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	3.9e-06	9.17e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	3.82e-06	9e-05	CbGpPWpGaD
Zileuton—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	3.79e-06	8.93e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	3.44e-06	8.09e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	3.29e-06	7.74e-05	CbGpPWpGaD
Zileuton—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	3.24e-06	7.63e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	3.01e-06	7.08e-05	CbGpPWpGaD
Zileuton—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	2.5e-06	5.89e-05	CbGpPWpGaD
